Gene · 369
NIH grants1,471
NIH grants whose papers are about the gene, through NIH's grant-paper links.
701 to 720 of 1,471
Download this page as JSON| Grant | Title | ARAF papers | Newest fiscal year |
|---|---|---|---|
| R01CA134563 | Synergy of Radiation and Immunotherapy: New Approaches | 1 | 2019 |
| R01CA177669 | Dynamical Models of Cetuximab Resistance in HNSCC Based on Serial Genomics Data | 1 | 2019 |
| R01CA184843 | Tumor Heterogeneity and Acquired Resistance to EGFR Inhibition | 1 | 2019 |
| R01CA186566 | Genome-Wide Association Study (GWAS) in Hepatocellular Carcinoma (HCC) | 1 | 2019 |
| R01CA187027 | Chemoprevention of colon cancer by targeting the Wnt/beta-catenin pathway | 1 | 2019 |
| R01CA187415 | MYC as a Biomarker in Aggressive Non-Hodgkin Lymphoma | 1 | 2019 |
| R01CA187918 | Targeting the p110beta isoform of PI3 kinase in prostate cancer | 1 | 2019 |
| R01CA190400 | Harnessing Csf-2 compartmentalized role on tissue resident phagocytes to uncouple anti-tumoral from pathological immunity induced by checkpoint inhibitors | 1 | 2019 |
| R01CA190642 | Unraveling resistance to PI3K-alpha inhibitors in breast cancer | 1 | 2019 |
| R01CA195670 | The Tumor Suppressor Role of SMARCA4 in SCCOHT | 1 | 2019 |
| R01CA196278 | Mutant BRAF-regulated transcription factors in melanoma progression | 1 | 2019 |
| R01CA196639 | Prevention of solar UV-induced skin cancer by targeting LTA4H | 1 | 2019 |
| R01CA197398 | Computational Model of Autophagy-Mediated Survival in Chemoresistant Lung Cancer | 1 | 2019 |
| R01CA197910 | Chronic inhibition of androgen receptor signaling leads to neuroendocrine prostate cancer by trans differentiation of stem/progenitor cells | 1 | 2019 |
| R01CA201513 | Notch signaling in small cell lung carcinoma | 1 | 2019 |
| R01CA206540 | Molecular and cellular mechanisms of SCLC metastasis | 1 | 2019 |
| R01DK103854 | U2AF1 mutations in myelodysplastic syndromes: from mechanism to therapy | 1 | 2019 |
| R01GM052872 | Regulation of RNA metabolism and cell growth control by SR protein kinases | 1 | 2019 |
| R01GM069668 | Spatial Segregation of Cell Functioning during Motility | 1 | 2019 |
| R01GM097455 | Sequence-based Design of Small Molecules Targeting RNA | 1 | 2019 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/369/grants?page=36